Clinical implications of measurement of serum nuclear matrix protein levels in patients with liver disease.

Abstract

BACKGROUND/AIMS Serum aminotransferase, a sensitive marker of hepatocellular damage, often poorly correlates with the severity of damage. Serum nuclear matrix protein (NMP), a structural protein released from dead cell nuclei, is investigated as a candidate marker of organ damage in liver disease. METHODOLOGY Serum NMP and aminotransferase levels of 134… (More)

Topics

Cite this paper

@article{Shimizu2005ClinicalIO, title={Clinical implications of measurement of serum nuclear matrix protein levels in patients with liver disease.}, author={Yuko Shimizu and Isao Nakano and Yoshiaki Katano and Hideyuki Shimizu and Yoshihide Fukuda}, journal={Hepato-gastroenterology}, year={2005}, volume={52 66}, pages={1809-13} }